Skip to main content

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1164508 BOSTON, MA

Position in RDY

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$1,421,605
-$3,781,915 QoQ
Shares Held
102,643
-74.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $805,226,112 across 23 Drug Manufacturers - Specialty & Generic names. RDY ranks #17 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RDY

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,421,605 102,643
2025-03-31 $5,203,520 394,505
2024-06-30 $3,546,796 46,552
2024-03-31 $7,698,155 104,951
2023-12-31 $2,023,525 29,082
2023-09-30 $16,653,706 249,046
2023-06-30 $9,290,296 147,208
2022-12-31 $455,658 8,805
2022-09-30 $536,589 10,252
2020-09-30 $4,331,849 62,275
2020-06-30 $10,567,914 199,357